Invest with impact.

Welcome to a new era of investing where you can back businesses with big ideas.

Equity Crowdfunding now live. 

Equity Crowdfunding has launched in Australia via OnMarket Crowd.


 Equity Crowdfunding Deals


Successful Raisings


Capital Raised


OnMarket Crowd

Discover investment opportunities here

Equity Crowdfunding is risky.  Please read the general risk warning.

IPO Live

Simble Solutions Ltd ASX: SIS

Simble Solutions Ltd

Simble Solutions Limited (ASX: SIS) is an Australian enterprise Software as a Service (SaaS) company focused on business and resource management. Its energy management solutions are principally catered towards enterprise and SME customers to reduce and manage their energy consumption. The platform is sold via channel partnerships in Australia, UK and NZ.

$6.5-7.5 millionSize of Offer
16 Jan 18Offer Open
09 Feb 18Pay By
IPO Live

Duxton Broadacre Farms Ltd ASX: DBF

Duxton Broadacre Farms Ltd

Update: Firm committments of at Least $15 million have been received.  Offer closing Friday 19th January.

Duxton Broadacre Farms Ltd (ASX: DBF) is expected to be the only ASX listed vehicle of its type in Australia, providing its investors with direct exposure grain production. It provides investors the opportunity to access the Australian grain industry via a portfolio of diversified dry land and irrigated broadacre farms located near Forbes in NSW.


$12-22 millionSize of Offer
29 Nov 17Offer Open
19 Jan 18Pay By
IPO OnMarket Bidding Closed

Rong Yu Pharma. Ltd ASX: RY8

Rong Yu Pharma. Ltd

Applications for the Rong Yu Pharmaceuticals IPO have closed via OnMarket.  The company has extended the offer until 16 March.  

Rong Yu Pharmaceuticals Ltd (ASX RY8) was founded in 2004 and is focussed on the development, manufacture and sale of prescription and OTC pharmaceutical products based on principles of Traditional Chinese Medicine. With revenue of A$71.4 million in FY2017, the Company’s products are sold in 28 Provinces across China via a network of over 300 wholesale distributors.

$15-20 millionSize of Offer
28 Nov 17Offer Open
16 Mar 18Pay By
Equity Crowdfunding Upcoming

Revvies Energy Strips Limited

Revvies: Upcoming Offer

Revolutionising the sports nutrition industry.


Disrupting the $70 billion energy food and drink market, Revvies are an ultrathin mouth strip containing 40 mg of caffeine. Revvies has rapidly been taken up by elite athletes and professional sporting teams including members of the Australian Olympic Team and is sold in over 475 retail outlets across Australia.

IPO Closed Dec 2017

Jayride Group Ltd ASX: JAY

Jayride Group Ltd

The Jayride Group Limited IPO has successfully closed. Allotment is expected to occur on or around 22nd January, and the ASX listing has been scheduled for 11am, Monday 29 January (AEDT). 

Please see the Replacement IPO Prospectus here

Fully Funded
$1.5 millionSize of Offer
NA Lead Manager
IPO Closed Dec 2017

CommsChoice Group Ltd ASX: CCG

CommsChoice Group Ltd

CommsChoice Group Ltd is a comprehensive vendor agnostic information and communications technology (ICT) managed service provider. 

Fully Funded
$7.5 millionSize of Offer
Baillieu Holst Lead Manager
Placement Closed Dec 2017

The Hydroponics Co. Ltd ASX: THC.

The Hydroponics Co. Ltd

The Hydroponics Company Ltd has successfully completed its $8 million placement. The proceeds will be used to expand both its Canadian and Australian Businesses.

See the company announcement here

Fully Funded
$8 millionSize of Offer
Hunter Capital Lead Manager
IPO Closed Nov 2017

SelfWealth Ltd ASX: SWF

SelfWealth Limited

View the Listing Ceremony here. SelfWealth Limited is a potentially disruptive flat fee online brokerage service with Peer to Peer portfolio construction functionality for investors. It assists clients with trading / portfolio decisions whilst providing them with access to competitive trading fees.

Fully Funded
TBDSize of Offer
Patersons Securities Lead Manager
IPO Closed Nov 2017

Rhythm Biosciences Ltd ASX: RHY

Rhythm Biosciences Ltd

Rhythm Biosciences Ltd is an Australian medical diagnostics company seeking to bring to market a simple blood test, ColoSTAT™, for the reliable early detection of colorectal cancer.

Fully Funded
$9.0 millionSize of Offer
Taylor Collison Lead Manager

Performance of OnMarket IPOs and Placements

Our performance has motivated members to share OnMarket, earning them over $172,000 in rewards.

The average returns by days post-listing are...

1 day (73*)
1 Month (73*)
3 months (73*)
6 months (73*)

* Number of offers that have listed at the time of calculation. Figures as at 1 December 2017.

Performance figures are calculated using a simple average method.

See comprehensive breakdown of returns

See past transactions

OnMarket partners include




OnMarket allows me to invest in companies that I want to see succeed and make an impact on the world, read my investor story


Risk warning

Crowd-sourced funding is risky. Issuers using this facility include new or rapidly growing ventures. Investment in these types of ventures is speculative and carries high risks. You may lose your entire investment, and you should be in a position to bear this risk without undue hardship. Even if the company is successful, the value of your investment and any return on the investment could be reduced if the company issues more shares. Your investment is unlikely to be liquid. This means you are unlikely to be able to sell your shares quickly or at all if you need the money or decide that this investment is not right for you.
Even though you have remedies for misleading statements in the offer document or misconduct by the company, you may have difficulty recovering your money. There are rules for handling your money. However, if your money is handled inappropriately or the person operating this platform becomes insolvent, you may have difficulty recovering your money. Ask questions, read all information given carefully, and seek independent financial advice before committing yourself to any investment.